Figure 5A shows the macrophages obtained from non-tumor-bearing animals treated with a dose of 0.9 μg/animal of CTX, showing no change in the percentage of M1 macrophages (CD45+F4/80+CD68+ cells) in the abdominal cavity when compared to the control group (PBS + saline). Here, PTPRC is linked to neoplasm.